TerminatedN/Aketamine

Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

NCT ID

NCT01170247

Target Enrollment

3 participants

Start Date

2011-01

Est. Completion

2012-01

About This Study

The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.

Conditions Studied

Sedation

Interventions

•Ketamine
•Ketamine

Eligibility

Age:2 Years - 17 Years

Healthy Volunteers:Yes

View full eligibility criteria

Inclusion Criteria:

* pediatric patients age 2 to 17 years old
* have a laceration of 4 cm on the face or 7 cm on the remainder of the body
* Require procedural sedation to repair the laceration

Exclusion Criteria:

* Patients with abnormal nasal physiology which would not allow for adequate medication delivery
* Unable to have a guardian present to consent on their behalf
* Allergy to ketamine
* Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
* Presenting with a head injury associated with possible intracranial hypertension
* Pregnancy
* Lacerations that require repair from a consult service

Study Locations (1)

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States